ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Agilent Brings Great Science to Life at Analytica 2024

Unveiling innovative automation capabilities and transformative workflows for analytical laboratories

Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows. Analytica, the premier international trade fair for laboratory technology, analysis, and biotechnology, is scheduled to take place from April 9 to 12 in Munich, Germany.

Visit Agilent at Hall A2, Booth 201, to learn about recently introduced products and solutions enabling key workflows that are revolutionizing laboratories across industries including pharma and biopharma, food and environment, chemical and energy, advanced materials, and molecular biology and cell analysis. Agilent technical experts will be available to share insights into these latest innovations and intuitive workflows.

  • Advanced Dilution System (ADS 2)

    Agilent’s newly launched Agilent ADS 2 is an intelligent autodilutor that seamlessly integrates with Agilent autosamplers, ICP-OES (inductively coupled plasma optical emission spectrometry), or ICP-MS (inductively coupled plasma mass spectrometry) instruments. Combined with cutting-edge software, ADS 2 provides customers with a fully integrated automation workflow solution.
  • BioTek Cytation C10 Confocal Imaging Reader

    Visit the Agilent booth for an exclusive first look at the upgraded BioTek Cytation C10 system, now equipped with water immersion and confocal spinning-disk technologies. These enhancements improve image quality, minimize deleterious effects on live-cell samples, and enhance clarity for thicker samples like tissues and 3-D spheroids.
  • 1290 Infinity II Bio Online LC Solution

    The Agilent 1290 Infinity II Bio Online LC Solution will be showcased alongside the MAST aseptic sampling system and Bioreactors from Merck KGaA, Darmstadt, Germany. This powerful combination demonstrates versatility and applicability across upstream and downstream bioprocessing applications.
  • ProteoAnalyzer

    The ProteoAnalyzer is an automated capillary electrophoresis instrument designed for assessing both reduced and non-reduced protein samples. Its streamlined workflow enhances efficiency and reliability, making protein quality control a breeze.

Agilent will also host several meet-and-greet specialist sessions in the booth.

  • Tuesday, 9 April, 4:00--5:00 pm Advanced Materials, and Energy and Chemicals Pods: Battery, Semiconductors, Alternative Energies.
  • Wednesday, 10 April, 4:00—5:00 pm Biopharma Pod: Oligo Analysis, online LC/PAT, Proteoanalyzer.
  • Thursday, 11 April, 4:00—5:00 pm Food & Environmental, and Pharma Pods: Dissolving Boundaries, Unmasking PFAS and Identifying Raw materials.

Agilent subject matter experts will also speak throughout the week at forum sessions. To learn more about Agilent’s complete activities at Analytica 2024 click here. Join us as we bring Great Science to Life!

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+0.00 (0.00%)
AAPL  278.85
+0.00 (0.00%)
AMD  217.53
+0.00 (0.00%)
BAC  53.65
+0.00 (0.00%)
GOOG  320.12
+0.00 (0.00%)
META  647.95
+0.00 (0.00%)
MSFT  492.01
+0.00 (0.00%)
NVDA  177.00
+0.00 (0.00%)
ORCL  201.95
+0.00 (0.00%)
TSLA  430.17
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.